Recombinant FSH dosing during controlled ovarian stimulation in IVF treatment

Aims
• Evaluate pharmacokinetics of rFSH by assessing serum FSH level.
• Identify dose-response relationships between rFSH dose and follicular growth.
• Determine the impact that rFSH dose adjustment has on follicle growth and number of mature oocytes retrieved.
• Recombinant FSH should be weight-adjusted.
• There is a dose-response relationship for starting GonalF dose at doses between 1.5 and 2.25 IU/kg to median follicle size after 5 days of treatment and to the proportion of antral follicles recruited.
• No further increased response beyond an rFSH dose of 2.25iU/kg
• Commencing COS with a sufficient starting dose of rFSH is advantageous reducing variability in follicle size and improving the number of mature oocytes retrieved. Results -Dose-response relationship between recombinant FSH dose and follicular growth Results -Adjusting rFSH dose and follicle growth 
